Search research articles
Contact Us
Filters
Showing results (31-40 of 40) with videos related to
Page
of 4
Sort By:
You have reached the last page of results.
This site can display upto 40 results.
Cancer Immunology Research
|
January 17, 2025
PRDM1 Is a Key Regulator of the NKT-cell Central Memory Program and Effector Function
Gengwen Tian, Gabriel A Barragan, Hangjin Yu, et al.
Nature Medicine
|
October 13, 2020
Anti-GD2 CAR-NKT cells in patients with relapsed or refractory neuroblastoma: an interim analysis
Andras Heczey, Amy N Courtney, Antonino Montalbano, et al.
Cancer Immunology Research
|
December 9, 2022
LEF1 Drives a Central Memory Program and Supports Antitumor Activity of Natural Killer T Cells
Ho Ngai, Gabriel A Barragan, Gengwen Tian, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
October 7, 2009
TSLP production by epithelial cells exposed to immunodeficiency virus triggers DC-mediated mucosal infection of CD4+ T cells
Danielle Fontenot, Hong He, Shino Hanabuchi, et al.
Journal for Immunotherapy of Cancer
|
January 12, 2025
Hyperleukocytosis in a neuroblastoma patient after treatment with natural killer T cells expressing a GD2-specific chimeric antigen receptor and IL-15
Gengwen Tian, Amy N Courtney, Hangjin Yu, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
January 11, 2026
IL-18 metabolically reprograms CAR-expressing natural killer T cells and enhances their antitumor activity
Gabriel A Barragán Bravo, David A de la Cerda, Elisa Landoni, et al.
Nature Medicine
|
January 9, 2024
Author Correction: Anti-GD2 CAR-NKT cells in relapsed or refractory neuroblastoma: updated phase 1 trial interim results
Andras Heczey, Xin Xu, Amy N Courtney, et al.
Nature Medicine
|
May 15, 2023
Anti-GD2 CAR-NKT cells in relapsed or refractory neuroblastoma: updated phase 1 trial interim results
Andras Heczey, Xin Xu, Amy N Courtney, et al.
Research Square
|
April 22, 2024
Interleukin-15-armored GPC3-CAR T cells for patients with solid cancers
David Steffin, Nisha Ghatwai, Antonino Montalbano, et al.
Nature
|
November 28, 2024
Interleukin-15-armoured GPC3 CAR T cells for patients with solid cancers
David Steffin, Nisha Ghatwai, Antonino Montalbano, et al.
Page
of 4
Search research articles
Search
Showing results (31-40 of 40) with videos related to
Sort By:
Page
of 4
You have reached the last page of results.
This site can display upto 40 results.
Cancer Immunology Research
|
January 17, 2025
PRDM1 Is a Key Regulator of the NKT-cell Central Memory Program and Effector Function
Gengwen Tian, Gabriel A Barragan, Hangjin Yu, et al.
Nature Medicine
|
October 13, 2020
Anti-GD2 CAR-NKT cells in patients with relapsed or refractory neuroblastoma: an interim analysis
Andras Heczey, Amy N Courtney, Antonino Montalbano, et al.
Cancer Immunology Research
|
December 9, 2022
LEF1 Drives a Central Memory Program and Supports Antitumor Activity of Natural Killer T Cells
Ho Ngai, Gabriel A Barragan, Gengwen Tian, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
October 7, 2009
TSLP production by epithelial cells exposed to immunodeficiency virus triggers DC-mediated mucosal infection of CD4+ T cells
Danielle Fontenot, Hong He, Shino Hanabuchi, et al.
Journal for Immunotherapy of Cancer
|
January 12, 2025
Hyperleukocytosis in a neuroblastoma patient after treatment with natural killer T cells expressing a GD2-specific chimeric antigen receptor and IL-15
Gengwen Tian, Amy N Courtney, Hangjin Yu, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
January 11, 2026
IL-18 metabolically reprograms CAR-expressing natural killer T cells and enhances their antitumor activity
Gabriel A Barragán Bravo, David A de la Cerda, Elisa Landoni, et al.
Nature Medicine
|
January 9, 2024
Author Correction: Anti-GD2 CAR-NKT cells in relapsed or refractory neuroblastoma: updated phase 1 trial interim results
Andras Heczey, Xin Xu, Amy N Courtney, et al.
Nature Medicine
|
May 15, 2023
Anti-GD2 CAR-NKT cells in relapsed or refractory neuroblastoma: updated phase 1 trial interim results
Andras Heczey, Xin Xu, Amy N Courtney, et al.
Research Square
|
April 22, 2024
Interleukin-15-armored GPC3-CAR T cells for patients with solid cancers
David Steffin, Nisha Ghatwai, Antonino Montalbano, et al.
Nature
|
November 28, 2024
Interleukin-15-armoured GPC3 CAR T cells for patients with solid cancers
David Steffin, Nisha Ghatwai, Antonino Montalbano, et al.
Page
of 4